Sort
59,101 grants matching “hypertension”
HMO Research Network Cardiovascular Research Network
$1,589,130Alan S Go · Kaiser Foundation Research Institute · U19 · FY2008 · HL
Marinobufagenin as a therapeutic target
$1,588,518Edward Lakatta · National Institute On Aging · ZIA · FY2020 · AG
Advanced Imaging for Glaucoma
$1,588,215Cleveland Clinic Lerner Col/Med-Cwru · R01 · FY2003 · EY
Minnesota Heart Survey - Renewal
$1,587,813Russell V Luepker · University Of Minnesota · R01 · FY2008 · HL
Inhibition Of Renal Injury
$1,587,394Robert A Star · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK
CREST-2 Statistical and Data Coordinating Center - SDCC
$1,587,333George Howard · University Of Alabama At Birmingham · U01 · FY2021 · NS
African American Eye Disease Study
$1,586,633Rohit Varma · University Of Southern California · U10 · FY2017 · EY
American Indian and Alaska Native Health Disparities
$1,586,229Spero M Manson · University Of Colorado Denver · U54 · FY2021 · MD
The Center for Advancing Point of Care in Heart, Lung, Blood and Sleep Diseases
$1,585,308David D. McManus · Univ Of Massachusetts Med Sch Worcester · U54 · FY2019 · HL
African Americans with Glaucoma: Structure and Function
$1,585,206University Of California San Diego · U10 · FY2003 · EY
Offspring Neurodevelopment and Growth after Early Antihypertensive Therapy OR Preeclampsia in Women with Chronic Hypertension and Pregnancy (CHAP Child).
$1,584,627Alan Thevenet N. Tita · University Of Alabama At Birmingham · R01 · FY2024 · HD
Achieving Outstanding Cardiovascular Health Outcomes for All Ohioans: a Statewide Cardiovascular Health Collaborative (Cardio-OH)
$1,584,382Shari Danielle Bolen · Case Western Reserve University · U18 · FY2021 · HS
Evaluating Predictors & Interventions in Sphincter of Oddi Dysfunction (EPISOD)
$1,584,047Peter B Cotton · Medical University Of South Carolina · U01 · FY2011 · DK
Regulation of Flt 1 Splicing by Fibronectin and Integrin Signaling During Aging
$1,583,383Patrick Andries Murphy · University Of Connecticut Sch Of Med/Dnt · RF1 · FY2023 · NS
FOcal Cerebral Arteriopathy Steroids (FOCAS) Trial
$1,583,157Heather J Fullerton · University Of California, San Francisco · UH3 · FY2024 · NS
Genetic Analysis of Complex Inflammatory Disorders
$1,583,024Daniel Kastner · National Human Genome Research Institute · ZIA · FY2024 · HG
A longitudinal cohort study to evaluate cardiovascular risk factors and disease in Haiti - 2
$1,581,146Margaret Leighton McNairy · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · HL
Initiation of a cohort to define pathogenic Mechanisms, Precision diagnosis And Complications of Thrombotic Microangiopathies: The IMPACT Study
$1,580,963Robert A Brodsky · Johns Hopkins University · U54 · FY2025 · HL
Experimental Neurogenic Hypertension Program
$1,580,470Costantino Iadecola · Weill Medical Coll Of Cornell Univ · P01 · FY2006 · HL
Interactions Between Inflammation, Oxidant Stress and Cardiovascular Disease
$1,580,415David G Harrison · Vanderbilt University · P01 · FY2013 · HL
National Sleep Research Resource (NSRR)
$1,580,311Susan S Redline · Brigham And Women'S Hospital · R24 · FY2015 · HL
Gene Therapy:Translating Basic Science to the Clinic
$1,579,670University Of California San Diego · P01 · FY2001 · HL
Biorepository and Coordinating Center for Studies on Cardiovascular Complications of Human Type 1 Diabetes
$1,579,049Mark A Atkinson · University Of Florida · U24 · FY2022 · DK
Experimental Neurogenic Hypertension Program
$1,577,994Costantino Iadecola · Weill Medical Coll Of Cornell Univ · P01 · FY2007 · HL
Targeting resitin and RELM-beta to treat pulmonary hypertension
$1,576,472Roger A Johns · Johns Hopkins University · UH2 · FY2015 · HL